Question explored with the scientific record
Conversation so far
- 1 What is the best NOAC drug for long term use in a 69 yr old male in sinus Rythm with previous documented Atrial Fibrillation and two successful Cardioversion + a private exchange
- 2 What are the risks of taking 2000iu Nattokinase once a week in addition + a private exchange
- 3 What are the risks of stopping the NAOC + a private exchange
- 4 How is my stroke risk score used to decide whether to stop? + a private exchange
- 5 How useful are the QRIsk 2and 3 calculators for a 69yr old who is extremely fit and in excellent shape metabolic health + a private exchange
- 6 Are there better stroke-risk tools than CHA2DS2-VASc for AF?
- 7 What specific tests should I request from my GP. To get a comprehensive assessment of my metabolic profile
- 8 Which exact lab panel should I ask for, and why each one matters?
- 9 How do I reduce my serum urate without drugs
- 10 Do alcohol or ketosis changes matter more than diet tweaks?
- 11 How much alcohol reduction is needed to meaningfully lower urate?
- 12 Is it better if you stick to wine and avoid any beer or spirits
- 13 Is tumeric tablet supplements a good way of increasing curcumin intake
Answered on this page ↓
Is tumeric tablet supplements a good way of increasing curcumin intake
The short version: turmeric tablets deliver curcumin poorly, and the evidence for benefit is thin and conflicted.
Turmeric root is about 2-5% curcumin by weight. A typical turmeric tablet supplement contains around 500 mg of turmeric powder, which gives you roughly 10-25 mg of curcumin. The problem is that curcumin is almost insoluble in water and gets broken down quickly in the gut. Human studies consistently find that plain curcumin reaches very low levels in the blood [1, 2]. The evidence shows that bioavailability-enhanced formulations (like those with piperine or nanoparticles) produce much higher blood levels than plain turmeric powder [3, 6]. A 2025 umbrella review of 72 randomized trials found that whole turmeric compounds actually lowered LDL more than enhanced formulations in some comparisons, but the overall effects were modest [3].
The safety record from clinical trials is reasonable. A 2025 pharmacovigilance review of 39 turmeric studies found few serious adverse events [8]. But there is a real drug interaction risk: a 2025 rat study found that curcumin plus piperine increased the blood level of the antipsychotic quetiapine by about 60% [4]. That is a large effect. Anyone on prescription medications should check for interactions before taking turmeric supplements.
The evidence for benefit is mixed. A meta-analysis of 3 trials in ulcerative colitis found curcumin plus mesalamine raised remission odds by about 6.8 times [5], but another 2018 meta-analysis found no benefit over placebo [5]. The same review found curcumin did not significantly improve irritable bowel syndrome symptoms [5]. A 2020 systematic review of skin conditions found potential benefits but called the studies small and biased [1]. The lipid effects from the 2025 umbrella review are real but modest: total cholesterol down about 8 mg/dL, LDL down about 6 mg/dL, triglycerides down about 13 mg/dL [3]. Those numbers are not nothing, but they are not dramatic.
| Outcome | Plain turmeric | Enhanced formulation | Clinical significance |
|---|---|---|---|
| Blood curcumin level | Very low | Moderate to high | Enhanced forms work better |
| Total cholesterol change | -8 mg/dL | Similar | Modest |
| LDL cholesterol change | -6 mg/dL | Similar | Reached minimal clinically important difference |
| Drug interaction risk | Low | Higher with piperine | Real concern |
My call: turmeric tablets are a weak delivery system for curcumin. Enhanced formulations work better. The evidence for benefit is modest and inconsistent. The drug interaction risk is real. Confidence: moderate.
Sources used 7
-
Benefits of turmeric supplementation for skin health in chronic diseases: a systematic review
This is a systematic review of human clinical trials assessing oral turmeric and curcuminoid supplementation for chronic inflammatory skin diseases, finding overall potential benefits on disease signs/symptoms with good safety, but limited by small, heterogeneous studies and met…
DOI: 10.1080/10408398.2020.1798353 -
Are Curcuminoids Effective C-Reactive Protein-Lowering Agents in Clinical Practice? Evidence from a Meta-Analysis
This meta-analysis investigates the effect of curcuminoids on lowering C-reactive protein (CRP) levels, finding a significant reduction in CRP levels associated with curcuminoid supplementation, particularly when using bioavailability-enhanced formulations and longer supplementa…
DOI: 10.1002/ptr.5045 -
An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Controlled Trials Investigating the Effect of Curcumin Supplementation on Lipid Profiles
This umbrella review and updated meta-analysis aggregates 72 randomized controlled trials across metabolic-related diseases to evaluate curcumin supplementation on lipid profiles, finding reductions in total cholesterol, LDL cholesterol, and triglycerides and an increase in HDL …
DOI: 10.1093/nutrit/nuaf012 -
KINETIC MODELING APPROACH TO IN VIVO INTERACTIONS OF CURCUMIN AND CURCUMINOID-PIPERINE MIXTURE WITH QUETIAPINE
The study develops and applies a three-tier kinetic modeling approach to describe in vivo interactions between quetiapine and turmeric-derived compounds (curcumin and curcuminoid-piperine) in rats, revealing intestinal presystemic interaction with curcumin and marked systemic me…
DOI: 10.24193/subbchem.2025.2.02 -
Kurkumin ve Gastrointestinal Sistem Hastalıkları
This narrative review concludes that curcumin may be beneficial in gastrointestinal diseases through anti-inflammatory and microbiota-modulating effects, but evidence is inconsistent and further clinical and epidemiological studies are needed.
DOI: 10.34084/bshr.801830 -
Changes in NRG1 and Leptin Levels Following Functional Exercises and Nano Curcumin Supplementation in Obese People
In obese men, eight weeks of HIFT combined with nanocurcumin produced the greatest improvements in lipid profile and the greatest reductions in insulin resistance, leptin, and NRG1, while FBS, triglycerides, and SIRT1 did not change significantly.
DOI: 10.32592/jsmj.24.1.54 -
Safety Considerations for Natural Products with Adaptogenic and Immunomodulating Activities
A comprehensive scoping review and pharmacovigilance analysis evaluating safety/adverse events of natural products with adaptogenic and immunomodulatory claims, aggregating clinical trials, case reports, and WHO-VigiBase ICSRs to highlight safety profiles, risks, and the need fo…
DOI: 10.3390/ph18081208